RLYBRallybio Corpvs its industry peers
A metric-by-metric comparison of Rallybio Corp against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RLYBEsta | $85M#3 | 3.4x#1 | 0.9x#2 | 99.3x#2 | 34.9%#1 | 84.5%#1 | -3853.6%#2 | -9.7%#1 | — | — | 184.6%#1 | — |
| UNCY | $94M#1 | — | 1.8x#3 | 139.1x#3 | -29.0%#3 | 27.7%#2 | -4372.9%#3 | -49.8%#2 | — | — | — | — |
| TNXP | $87M#2 | — | 0.4x#1 | 6.7x#1 | 29.8%#2 | 4.6%#3 | -959.1%#1 | -55.8%#3 | -234.8%#1 | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice